This inventor holds 6 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2009-2016.
Company Filing History:
Years Active: 2009-2016
Title: Innovations by Sung-Kee Chung
Introduction
Sung-Kee Chung is a notable inventor based in Pohang-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 6 patents to his name, his work has garnered attention for its potential impact on medical science.
Latest Patents
One of his latest patents involves trehalose derivatives and pharmaceutical compositions for treating neurodegenerative diseases. The invented inositol and trehalose derivatives, prepared by introducing multiple units of the guanidine group to the backbone molecules, show excellent blood-brain barrier permeability. Consequently, these compounds can be easily transported to brain tissues and utilized for the treatment of neurodegenerative diseases such as Alzheimer's disease and Huntington's disease. Another significant patent focuses on molecular transporters based on sugar and its analogues, along with processes for their preparation. This inventive molecular transporter compound demonstrates significantly high permeability through biological membranes, including the plasma membrane, nuclear membrane, and blood-brain barrier. As a result, it can be effectively used in delivering various biologically active molecules.
Career Highlights
Sung-Kee Chung has worked with reputable organizations such as the Postech Foundation and the Postech Academy-Industry Foundation. His career reflects a commitment to advancing research and innovation in the pharmaceutical sector.
Collaborations
Throughout his career, he has collaborated with notable colleagues, including Woo Sirl Lee and Kaustabh Kumar Maiti. These partnerships have contributed to the development of his innovative ideas and patents.
Conclusion
Sung-Kee Chung's work exemplifies the intersection of innovation and medical science, particularly in addressing critical health challenges. His contributions continue to pave the way for advancements in the treatment of neurodegenerative diseases.